Systemic Adverse Events Associated with Compounded Topical Pain Products

Jenny Kim (), Karen Konkel, S. Christopher Jones and Lynda McCulley
Additional contact information
Jenny Kim: U.S. Food and Drug Administration
Karen Konkel: U.S. Food and Drug Administration
S. Christopher Jones: U.S. Food and Drug Administration
Lynda McCulley: U.S. Food and Drug Administration

Drug Safety, 2020, vol. 43, issue 5, No 10, 497-501

Date: 2020
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-020-00927-2 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:43:y:2020:i:5:d:10.1007_s40264-020-00927-2

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-020-00927-2

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().